﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>11</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2021</Year>
        <Month>02</Month>
        <DAY>27</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Humanized Culture Medium for Clinical-Grade Generation of Erythroid Cells from Umbilical Cord Blood CD34+ Cells</ArticleTitle>
    <FirstPage>335</FirstPage>
    <LastPage>342</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.2021.031</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Zamani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-7260-2348</Identifier>
      </Author>
      <Author>
        <FirstName>Yoda</FirstName>
        <LastName>Yaghoubi</LastName>
      </Author>
      <Author>
        <FirstName>Adel</FirstName>
        <LastName>Naimi</LastName>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Hassanzadeh</LastName>
      </Author>
      <Author>
        <FirstName>Ramin</FirstName>
        <LastName>Pourakbari</LastName>
      </Author>
      <Author>
        <FirstName>Leili</FirstName>
        <LastName>Aghebati-Maleki</LastName>
      </Author>
      <Author>
        <FirstName>Roza</FirstName>
        <LastName>Motavalli</LastName>
      </Author>
      <Author>
        <FirstName>Afsoon</FirstName>
        <LastName>Aghlmandi</LastName>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Mehdizadeh</LastName>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Nazari</LastName>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Yousefi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0099-6728</Identifier>
      </Author>
      <Author>
        <FirstName>Ali Akbar</FirstName>
        <LastName>Movassaghpour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6990-9269</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.2021.031</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>01</Month>
        <Day>21</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>02</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: Transfusion of red blood cells (RBCs) is a supportive and common treatment in surgical care, trauma, and anemia. However, in vivo production of RBC seems to be a suitable alternative for blood transfusions due to the limitation of blood resources, the possibility of disease transmission, immune reactions, and the presence of rare blood groups. Cell cultures require serum-free or culture media supplemented with highly expensive animal serum, which can transmit xenoviruses. Platelet lysate (PL) can be considered as a suitable alternative containing a high level of growth factors and a low production cost. Methods: Three-step culture media supplemented with PL or fetal bovine serum (FBS) were used for proliferation and differentiation of CD34+ umbilical cord blood stem cells to erythrocytes in co-culture with bone marrow mesenchymal stem cells (BM-MSCs). The cells were cultivated for 15 days and cell proliferation and expansion were assessed using cell counts at different days. Erythroid differentiation genes, CD71 and glycophorin A expression levels were evaluated. Results: Maximum hematopoietic stem cells (HSCs) proliferation was observed on day 15 in PL-containing medium (99±17×103 -fold). Gene expression and surface markers showed higher differentiation of cells in PL-containing medium. Conclusion: The results of this study indicate that PL can enhance erythroid proliferation and differentiation of CD34+ HSCs. PL can also be used as a proper alternative for FBS in the culture medium and HSCs differentiation. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Human platelet lysate</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Fetal bovine serum</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">CD34+ hematopoietic stem cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Erythroid differentiation</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>